Busulfan Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-10-24 · last update 2025-10-24
Manufacturers: Mylan Institutional, a Viatris Company
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Busulfan, Injection, 6 mg/1 mL (NDC 67457-893-08) | Mylan Institutional, a Viatris Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug. | Posted 10/24/2025 Updated 10/24/2025 Discontinued 10/24/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)